1. Home
  2. News
  3. Telix Pharmaceuticals Limited
  4. Telix and Xiel Sign U.K. and Ireland Distribution Agreement
More Telix Pharmaceuticals Limited news
Telix Pharmaceuticals LimitedASX: TLX

Telix and Xiel Sign U.K. and Ireland Distribution Agreement

Mar 28, 2022 at 10:13 PM EDT · Issued by Telix Pharmaceuticals Limited

Filed with ASX · Mar 28, 2022 at 10:13 PM EDT · 3 pages · English

On 6ix: 6ix.com/news/telix-and-xiel-sign-uk-and-ireland-distribution-agreement

Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20↗

Telix Pharmaceuticals Limited on 6ix

Earlier from Telix Pharmaceuticals

  • Development of Glioblastoma Therapy ProgramMar 22, 2022
  • Radiopharmaceutical Production Facility Buildout CommencesMar 21, 2022
  • ZIRCON Phase 3 Imaging Study Completes Targets EnrolmentMar 7, 2022
  • Cancellation of Share Purchase PlanMar 1, 2022
  • 2021 Full Year Results PresentationFeb 23, 2022

Later from Telix Pharmaceuticals

  • FDA Orphan Drug Designation for Bone Marrow ConditioningMar 29, 2022
  • Commercial Launch - Illuccix Now Available to Order in USApr 3, 2022
  • Telix, GMS & Monash Awarded $23 million Federal FundingApr 4, 2022
  • Telix Enters Licence Agreement with Lilly for OlaratumabApr 10, 2022
  • ProstACT TARGET Phase II Study Ethics ApprovalApr 11, 2022
All Telix Pharmaceuticals news releases↗

Follow Telix Pharmaceuticals into a list and get an email when it puts out news.

Follow Telix Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer